HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.

Abstract
Overexpression of the rate-limiting enzyme for hexosamine synthesis (glutamine:fructose-6-phosphate amidotransferase) in muscle and adipose tissue of transgenic mice was previously shown to result in insulin resistance and hyperleptinemia. Explanted muscle from transgenic mice was not insulin resistant in vitro, suggesting that muscle insulin resistance could be mediated by soluble factors from fat tissue. To dissect the relative contributions of muscle and fat to hexosamine-induced insulin resistance, we overexpressed glutamine:fructose-6-phosphate amidotransferase 2.5-fold, specifically in fat under control of the aP2 promoter. Fasting glucose, insulin, and triglycerides were unchanged in the transgenic mice; leptin and beta-hydroxybutyrate levels were 91% and 29% higher, respectively. Fasted transgenic mice have mild glucose intolerance and skeletal muscle insulin resistance in vivo. In fasting transgenic mice, glucose disposal rates with hyperinsulinemia were decreased 27% in females and 10% in males. Uptake of 2-deoxy-D-glucose into muscle was diminished by 45% in female and 21% in male transgenics. Serum adiponectin was also lower in the fasted transgenics, by 37% in females and 22% in males. TNF alpha and resistin mRNA levels in adipose tissue were not altered in the fasted transgenics; levels of mRNA for leptin were increased and peroxisome proliferator-activated receptor gamma decreased. To further explore the relationship between adiponectin and insulin sensitivity, we examined mice that have been refed for 6 h after a 24-h fast. Refeeding wild-type mice resulted in decreased serum adiponectin and increased leptin. In transgenic mice, however, the regulation of these hormones by refeeding was lost for adiponectin and diminished for leptin. Refed transgenic female and male mice no longer exhibited decreased serum adiponectin in the refed state, and they were no longer insulin resistant as by lower or unchanged insulin and glucose levels. We conclude that increased hexosamine levels in fat, mimicking excess nutrient delivery, are sufficient to cause insulin resistance in skeletal muscle. Changes in serum adiponectin correlate with the insulin resistance of the transgenic animals.
AuthorsMark Hazel, Robert C Cooksey, Deborah Jones, Glendon Parker, John L Neidigh, Bryan Witherbee, Eric A Gulve, Donald A McClain
JournalEndocrinology (Endocrinology) Vol. 145 Issue 5 Pg. 2118-28 (May 2004) ISSN: 0013-7227 [Print] United States
PMID14684615 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Adiponectin
  • Blood Glucose
  • Hexosamines
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • Leptin
  • Proteins
  • RNA, Messenger
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • Triglycerides
  • Deoxyglucose
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
  • 3-Hydroxybutyric Acid
Topics
  • 3-Hydroxybutyric Acid (blood)
  • Adiponectin
  • Adipose Tissue (metabolism)
  • Animals
  • Blood Glucose (analysis)
  • Deoxyglucose (metabolism)
  • Fasting
  • Female
  • Food
  • Gene Expression
  • Glucose Intolerance (enzymology)
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) (genetics)
  • Hexosamines (biosynthesis, physiology)
  • Humans
  • Insulin (blood)
  • Insulin Resistance
  • Intercellular Signaling Peptides and Proteins
  • Leptin (blood, genetics)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscle, Skeletal (drug effects, metabolism)
  • Proteins (analysis)
  • RNA, Messenger (analysis)
  • Receptors, Cytoplasmic and Nuclear (genetics)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Transcription Factors (genetics)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: